vaccine

By Julie SteenhuysenCHICAGO, July 30 (Reuters) - Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.When exposed to the virus, six out of six animals who got the…

By Alice Klein A new Lyme disease vaccine is on the wayHailshadow/Getty Images/iStockph A vaccine against Lyme disease has been shown to be safe and effective in a clinical trial and could be available by 2025. Tens of thousands of people in the US  and in Europe are diagnosed each year with Lyme disease, which…

The first coronavirus vaccine may arrive soon, but it’s unlikely to be the knockout punch you may be hoping for.Why it matters: The end of this global pandemic almost certainly rests with a vaccine. Experts caution, however, that it’s important to have realistic expectations about how much the first vaccines across the finish line will…

Share on PinterestThe results of a phase II clinical trial show that a new COVID-19 vaccine is safe and able to trigger an immune response. With over 15 million confirmed cases of the new coronavirus, SARS-CoV-2, and more than 624,000 COVID-19 deaths globally, scientists around the world are competing against time to fast-track the development…

Bill Gates on "serious mistakes" in COVID response Bill Gates on "serious mistakes" in COVID res... 28:30 Microsoft co-founder Bill Gates said Wednesday that people could need multiple doses of a potential coronavirus vaccine to immunize themselves from the coronavirus. If necessary, the multiple doses could require more than 7 billion vaccinations to be administered…